Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.50
+0.05 (0.92%)
At close: Mar 27, 2026
Market Cap1.35B +13.0%
Revenue (ttm)106.02M +78.0%
Net Income-42.47M
EPS-0.18
Shares Out244.71M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume59,000
Average Volume42,220
Open5.47
Previous Close5.45
Day's Range5.40 - 5.50
52-Week Range3.20 - 14.02
Beta-1.18
RSI39.21
Earnings DateMar 27, 2026

About HKG:6922

Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, engages in the research and development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products in the People’s Republic of China. The company develops products in the areas of vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases... [Read more]

Sector Healthcare
Founded 2013
Employees 180
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6922
Full Company Profile

Financial Performance

In 2025, HKG:6922's revenue was 95.27 million, an increase of 77.97% compared to the previous year's 53.53 million. Losses were -38.17 million, -63.43% less than in 2024.

Financial numbers in CNY Financial Statements